PubMed · 4756639
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
M S Boĭko. 1973. [Microclimate, feeds, milk quality].. https://pubmed.ncbi.nlm.nih.gov/4756639/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Zearalenone (ZEA), a Fusarium toxin, is frequently found in animal feed materials. It is known to exert oestrogenic effects in all animals tested but susceptibility varies between species, possibly reflecting differences in the metabolic processing of ZEA, which predominantly involves hydroxylations, assumed to be catalysed by 3alpha- and 3beta- hydroxysteroid dehydrogenases, as well as conjugation with glucuronic acid. In this study, the biotransformation of ZEA by hepatic subcellular fractions of various domestic animals was investigated and compared to the rat. Notable inter-species differences in terms of the rate of absolute and relative metabolite production in the different subcellular fractions were identified. The highest amount of alpha-zearalenol (alpha-ZOL) was produced by pig hepatic microsomes (V(max)=795.8+/-122.7pmol/mg/min), whereas in chicken microsomes the highest amounts of beta-zearalenol (beta-ZOL) (V(max)=1524+/-29.7pmol/mg/min) could be measured. Except for sheep and cattle, the efficiency of alpha-ZOL production (expressed as the ratio of apparent V(max)/k(m)) was higher in the microsomal fraction compared to the post-mitochondrial fraction. In contrast, the apparent efficiency of beta-ZOL production was high in pigs, cattle, chickens and rats, but very low in sheep. Conjugation of ZEA with glucuronic acid was investigated, and the results indicated significant inter-species differences in the rate of glucuronidation, which was saturable at low concentrations in all species tested, except pigs. The significant differences between the percentages of glucuronidation of ZEA, alpha-ZOL, and beta-ZOL suggest not only differences in the affinity of the individual substrate, but might also indicate the presence of different isoforms of uridine diphosphate glucuronyl transferases (UDPGTs). The results are of clinical relevance, as they contribute to the understanding of the species-specific susceptibility towards exposure to ZEA.
The effect of fish oils and their active omega-3 fatty acid constituents, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), were investigated on breast cancer growth. In in vivo experiments, mice were fed diets that were rich in either omega-3 (fish oil) or omega-6 (corn oil) fatty acids. Three weeks after implantation of MDA-MB-231 breast cancer cells, the tumor volume and weight were significantly lower (p < 0.05) for mice fed the omega-3 diets compared to those fed the omega-6 diets. Dietary fish oil also caused a 40% (p < 0.05) increase in neutral sphingomyelinase (N-SMYase) activity in the tumors. The tumor tissues from fish oil-fed animals expressed elevated p21 (waf1/cip1) mRNA, whereas tumor tissues from corn oil-fed animals exhibited undetectable levels of p21 expression. In in vitro experiments, at concentrations as low as 25 muM, DHA and EPA inhibited the growth of cultured MDA-MB-231 cells in a dose-dependent manner by 20-25% (p < 0.05). N-SMYase activity was also increased by 30-40% (p < 0.05) in the DHA- or EPA-treated cells in which an increase in ceramide formation was observed. DHA and EPA were both observed to enhance membrane bleb formation and also to induce the expression of p21. Omega-3 fatty acids-induced bleb formation and p21 expression were inhibited by the N-SMYase inhibitor GW4869, which also inhibited apoptosis by approximately 40% (p < 0.05). The results suggest that inhibition of breast cancer growth in nude mice by dietary fish oil and inhibition of breast cancer cell growth in culture by treatment with DHA and EPA is mediated by activation of N-SMYase.
Lead is pervasive environmental pollutant with potential public health hazard as a contaminant of food from animal origin. The present study examines the blood and milk lead level in animals reared in areas around different industrial activities and to find out correlation between blood and milk lead levels in lactating cows. Blood and milk samples (n = 149) were collected from animals reared around steel processing unit (n = 22), lead-zinc smelter (n = 21), aluminum processing plant (n = 25), rock phosphate mining area cum phosphate fertilizer plant (n = 21), coal mining areas (n = 46) and closed lead but functional zinc smelter (n = 14). Samples were also collected from randomly chosen 52 lactating cows reared in non-polluted areas to serve as controls. Significantly (P < 0.05) higher blood lead level was recorded in animals reared around lead-zinc smelting factories followed by closed lead but functional zinc smelter, aluminum processing unit and steel manufacturing plant, as compared to values recorded for control animals. The highest milk lead level (0.84 +/- 0.11 microg/ ml) was detected in animals reared in the vicinity of lead-zinc smelting unit followed by aluminum processing plant and steel processing unit. Analysis of correlation between blood lead levels and lead excretion in milk through sorting the blood lead values into 9 different ranges irrespective of site of collection of samples (n = 201) revealed significant correlation (r = 0.469 at P < 0.01) between blood and milk lead concentrations. The lactating cows with blood lead levels above 0.20 microg/ml (groups 5-9) had significantly (P < 0.05) higher milk lead excretion than those with blood lead levels from non detectable to 0.20 microg/ml (groups 1-4). Pearson correlation analysis between blood and milk lead concentrations in 122 animals with blood lead <0.20 microg/ml showed non-significant correlation (r = 0.030 at P < 0.05) but a significant correlation was observed between these two parameters with blood lead level above >0.02 microg/ml indicating that the excretion of lead through milk increases with the increased in blood lead level above 0.20 microg/ml.